TNF-α-mediated JNK activation in the dorsal root ganglion neurons contributes to Bortezomib-induced peripheral neuropathy

Brain, Behavior, and Immunity

Volumn 38, Issue , 2014, Pages 185-191

  Zhang, Jie ^a   Su, Yi Min ^a   Li, Dai ^a   Cui, Yu ^a   Huang, Zhen Zhen ^a   Wei, Jia You ^a   Xue, Zi ^a   Pang, Rui Ping ^a   Liu, Xian Guo ^a   Xin, Wen Jun ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Allodynia; Bortezomib; DRG; JNK; TNF

Indexed keywords

BORTEZOMIB; MITOGEN ACTIVATED PROTEIN KINASE 9; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE 1; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 1; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 2; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; BORONIC ACID DERIVATIVE; PYRAZINE DERIVATIVE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE INACTIVATION; MALE; NEUROPATHOLOGY; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BLOCKING; SPINAL GANGLION; UPREGULATION; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; ENZYMOLOGY; HYPERALGESIA; METABOLISM; NERVE CELL; SPRAGUE DAWLEY RAT; TOXICITY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; SENSORY NERVE CELL; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; BORONIC ACIDS; GANGLIA, SPINAL; HYPERALGESIA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MICE, INBRED C57BL; NEURONS; PERIPHERAL NERVOUS SYSTEM DISEASES; PYRAZINES; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84898548790     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.01.020     Document Type: Article

References (46)

1. Argyriou A.A., Iconomou G., Kalofonos H.P. Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature. Blood 2008, 112:1593-1599.
2. Burgos E., Gomez-Nicola D., Pascual D., Martin M.I., Nieto-Sampedro M., Goicoechea C. Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells. Eur. J. Pharmacol. 2012, 682:62-72.
3. Carozzi V.A., Chiorazzi A., Canta A., Lapidus R.G., Slusher B.S., Wozniak K.M., Cavaletti G. Glutamate carboxypeptidase inhibition reduces the severity of chemotherapy-induced peripheral neurotoxicity in rat. Neurotox. Res. 2010, 17:380-391.
4. Cata J.P., Weng H.R., Burton A.W., Villareal H., Giralt S., Dougherty P.M. Quantitative sensory findings in patients with bortezomib-induced pain. J. pain 2007, 8:296-306.
5. Cata J.P., Weng H.R., Dougherty P.M. The effects of thalidomide and minocycline on taxol-induced hyperalgesia in rats. Brain Res. 2008, 1229:100-110.
6. Cavaletti G., Gilardini A., Canta A., Rigamonti L., Rodriguez-Menendez V., Ceresa C., Marmiroli P., Bossi M., Oggioni N., D'Incalci M., De Coster R. Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat. Exp. Neurol. 2007, 204:317-325.
7. Chadwick W., Magnus T., Martin B., Keselman A., Mattson M.P., Maudsley S. Targeting TNF-alpha receptors for neurotherapeutics. Trends Neurosci. 2008, 31:504-511.
8. Constantin C.E., Mair N., Sailer C.A., Andratsch M., Xu Z.Z., Blumer M.J., Scherbakov N., Davis J.B., Bluethmann H., Ji R.R., Kress M. Endogenous tumor necrosis factor alpha (TNFalpha) requires TNF receptor type 2 to generate heat hyperalgesia in a mouse cancer model. J. Neurosci. 2008, 28:5072-5081.
9. Curran M.P., McKeage K. Bortezomib: a review of its use in patients with multiple myeloma. Drugs 2009, 69:859-888.
10. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 2000, 103:239-252.
11. Gao Y.J., Ji R.R. Activation of JNK pathway in persistent pain. Neurosci. Lett. 2008, 437:180-183.
12. Gao Y.J., Zhang L., Samad O.A., Suter M.R., Yasuhiko K., Xu Z.Z., Park J.Y., Lind A.L., Ma Q., Ji R.R. JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J. Neurosci. 2009, 29:4096-4108.
13. Gong Q.J., Li Y.Y., Xin W.J., Zang Y., Ren W.J., Wei X.H., Zhang T., Liu X.G. ATP induces long-term potentiation of C-fiber-evoked field potentials in spinal dorsal horn: the roles of P2X4 receptors and p38 MAPK in microglia. Glia 2009, 57:583-591.
14. Gosselin D., Rivest S. Role of IL-1 and TNF in the brain: twenty years of progress on a Dr. Jekyll/Mr. Hyde duality of the innate immune system. Brain Behav. Immun. 2007, 21:281-289.
15. Grisold W., Cavaletti G., Windebank A.J. Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro-oncology 2012, 14(Suppl. 4):iv45-iv54.
16. Gupta S., Barrett T., Whitmarsh A.J., Cavanagh J., Sluss H.K., Derijard B., Davis R.J. Selective interaction of JNK protein kinase isoforms with transcription factors. Embo. J. 1996, 15:2760-2770.
17. He X.H., Zang Y., Chen X., Pang R.P., Xu J.T., Zhou X., Wei X.H., Li Y.Y., Xin W.J., Qin Z.H., Liu X.G. TNF-alpha contributes to up-regulation of Nav1.3 and Nav1.8 in DRG neurons following motor fiber injury. Pain 2010, 151:266-279.
18. Hideshima T., Chauhan D., Castro A., Hayashi T., Mitsiades C., Mitsiades N., Akiyama M., Richardson P.G., Schlossman R.L., Adams J., Anderson K.C. NF-kappa B as a therapeutic target in multiple myeloma (MM). Blood 2001, 98:375a.
19. Hou L.F., Li W.J., Wang X. Mechanism of interleukin-1 beta-induced calcitonin gene-related peptide production from dorsal root ganglion neurons of neonatal rats. J. Neurosci. Res. 2003, 73:188-197.
20. Kennedy B., Gargoum F., Bystricky B., Curran D.R., O'Connor T.M. Novel agents in the management of lung cancer. Curr. Med. Chem. 2010, 17:4291-4325.
21. Kiguchi N., Maeda T., Kobayashi Y., Kishioka S. Up-regulation of tumor necrosis factor-alpha in spinal cord contributes to vincristine-induced mechanical allodynia in mice. Neurosci. Lett. 2008, 445:140-143.
22. Kiguchi N., Maeda T., Kobayashi Y., Saika F., Kishioka S. Involvement of inflammatory mediators in neuropathic pain caused by vincristine. Int. Rev. Neurobiol. 2009, 85:179-190.
23. Lenz H.J. Clinical update: proteasome inhibitors in solid tumors. Cancer Treat Rev. 2003, 29:41-48.
24. Leung L., Cahill C.M. TNF-alpha and neuropathic pain-a review. J. Neuroinflamm. 2010, 7.
25. Liu C.C., Lu N., Cui Y., Yang T., Zhao Z.Q., Xin W.J., Liu X.G. Prevention of paclitaxel-induced allodynia by minocycline: effect on loss of peripheral nerve fibers and infiltration of macrophages in rats. Molecular pain 2010, 6:76.
26. Meregalli C., Canta A., Carozzi V.A., Chiorazzi A., Oggioni N., Gilardini A., Ceresa C., Avezza F., Crippa L., Marmiroli P., Cavaletti G. Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats. Eur. J. Pain 2010, 14:343-350.
27. Norcini M., Vivoli E., Galeotti N., Bianchi E., Bartolini A., Ghelardini C. Supraspinal role of protein kinase C in oxaliplatin-induced neuropathy in rat. Pain 2009, 146:141-147.
28. + mobilisation and stress kinases in cultured sensory neurones. Neuropharmacology 2002, 42:93-106.
29. Raghavendra V., Rutkowski M.D., DeLeo J.A. The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats. J. Neurosci. 2002, 22:9980-9989.
30. Schafers M., Lee D.H., Brors D., Yaksh T.L., Sorkin L.S. Increased sensitivity of injured and adjacent uninjured rat primary sensory neurons to exogenous tumor necrosis factor-alpha after spinal nerve ligation. J. Neurosci. 2003, 23:3028-3038.
31. Schafers M., Sommer C., Geis C., Hagenacker T., Vandenabeele P., Sorkin L.S. Selective stimulation of either tumor necrosis factor receptor differentially induces pain behavior in vivo and ectopic activity in sensory neurons in vitro. Neuroscience 2008, 157:414-423.
32. Schafers M., Svensson C.I., Sommer C., Sorkin L.S. Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J. Neurosci. 2003, 23:2517-2521.
33. Sommer C., Lindenlaub T., Teuteberg P., Schafers M., Hartung T., Toyka K.V. Anti-TNF-neutralizing antibodies reduce pain-related behavior in two different mouse models of painful mononeuropathy. Brain Res. 2001, 913:86-89.
34. Sommer C., Schafers M., Marziniak M., Toyka K.V. Etanercept reduces hyperalgesia in experimental painful neuropathy. J. Peripher. Nerv. Syst. 2001, 6:67-72.
35. Sommer C., Schmidt C., George A. Hyperalgesia in experimental neuropathy is dependent on the TNF receptor 1. Exp. Neurol. 1998, 151:138-142.
36. Tobinai K. Proteasome inhibitor, bortezomib, for myeloma and lymphoma. Int. J. Clin. Oncol. 2007, 12:318-326.
37. Vogel C., Stallforth S., Sommer C. Altered pain behavior and regeneration after nerve injury in TNF receptor deficient mice. J. Peripher. Nerv. Syst. 2006, 11:294-303.
38. Watkins L.R., Maier S.F. Glia: a novel drug discovery target for clinical pain. Nat. Rev. Drug Discov. 2003, 2:973-985.
39. Wei X.H., Zang Y., Wu C.Y., Xu J.T., Xin W.J., Liu X.G. Peri-sciatic administration of recombinant rat TNF-alpha induces mechanical allodynia via upregulation of TNF-alpha in dorsal root ganglia and in spinal dorsal horn: the role of NF-kappa B pathway. Exp. Neurol. 2007, 205:471-484.
40. Wen Y.R., Tan P.H., Cheng J.K., Liu Y.C., Ji R.R. Microglia: a promising target for treating neuropathic and postoperative pain, and morphine tolerance. J. Formos. Med. Assoc. 2011, 110:487-494.
41. Winkelstein B.A., Rutkowski M.D., Sweitzer S.M., Pahl J.L., DeLeo J.A. Nerve injury proximal or distal to the DRG induces similar spinal glial activation and selective cytokine expression but differential behavioral responses to pharmacologic treatment. J. Comp. Neurol. 2001, 439:127-139.
42. Xu J.-T., Xin W.-J., Wei X.-H., Wu C.-Y., Ge Y.-X., Liu Y.-L., Zang Y., Zhang T., Li Y.-Y., Liu X.-G. P38 activation in uninjured primary afferent neurons and in spinal microglia contributes to the development of neuropathic pain induced by selective motor fiber injury. Exp. Neurol. 2007, 204:355-365.
43. Xu Q.H., Yaksh T.L. A brief comparison of the pathophysiology of inflammatory versus neuropathic pain. Curr. Opin. Anesthesio. 2011, 24:400-407.
44. Yang J., He J., Wang J., Cao Y., Ling J., Qian J., Lu Y., Li H., Zheng Y., Lan Y., Hong S., Matthews J., Starbuck M.W., Navone N.M., Orlowski R.Z., Lin P., Kwak L.W., Yi Q. Constitutive activation of p38 MAPK in tumor cells contributes to osteolytic bone lesions in multiple myeloma. Leukemia 2012, 26:2114-2123.
45. Zheng H., Xiao W.H., Bennett G.J. Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy. Exp. Neurol. 2012, 238:225-234.
46. Zhuang Z.Y., Wen Y.R., Zhang D.R., Borsello T., Bonny C., Strichartz G.R., Decosterd I., Ji R.R. A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. J. Neurosci. 2006, 26:3551-3560.